Changes in the gut microbiome are associated with numerous diseases. Research shows – convincingly – that microbiome modulation may lead to a cure. Why is it then, that the efforts to treat patients by targeting the gut microbiome fail?
This brief White Paper discusses the state-of-the-art of the microbiome as a therapeutic target, the reasons hampering the translation of microbiome research into humans, and propositions to tackle the hurdles in microbiome-related clinical development.
Please click on the following url: